Amphotericin B for Cryptococcal Meningitis in HIV Positive Patients: Low Dose Versus High Dose

Indian Journal of Critical Care Medicine - India
doi 10.4103/0972-5229.35083
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Jaypee Brothers Medical Publishing

Related search

A Phase II Randomized Controlled Trial Adding Oral Flucytosine to High-Dose Fluconazole, With Short-Course Amphotericin B, for Cryptococcal Meningitis

AIDS
Infectious DiseasesAllergyImmunology
2012English

Risk Factors in HIV/AIDS Patients With Cryptococcal Meningitis

BMC Infectious Diseases
Infectious Diseases
2014English

Low Dose Liposomal Amphotericin B Seems to Be Effective Against Visceral Leishmaniasis

BMJ
2001English

Heparin for Coronary Angioplasty: High Dose, Low Dose, or No Dose?

Heart
Cardiovascular MedicineCardiology
1998English

Management of Amphotericin-Induced Phlebitis Among HIV Patients With Cryptococcal Meningitis in a Resource-Limited Setting: A Prospective Cohort Study

BMC Infectious Diseases
Infectious Diseases
2019English

Low-Dose Versus Standard-Dose Tissue Plasminogen Activator for Intravenous Thrombolysis in Asian Acute Ischemic Stroke Patients

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2010English

Emerging Concepts in HIV-associated Cryptococcal Meningitis

Current Opinion in Infectious Diseases
Infectious DiseasesMicrobiology
2019English

Amphotericin B Deoxycholate in Adults With Cryptococcal Meningitis; A Population Pharmacokinetic Model and Meta-Analysis of Outcomes

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2018English

Recent Advances in Managing HIV-associated Cryptococcal Meningitis

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy